본문 바로가기

Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
저널
LEUKEMIA RESEARCH49 · pp.80 · 2016
피인용
Web of Science 12
JCR IF
JCR 2015 2.606
ISSN
0145-2126

저자

  1. Moon, Joon-Ho제1저자Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, South Korea
  2. Lee, Bo-HeeDivision of Hematology, Department of Internal Medicine, St. Vincent's hospital, The Catholic University of Korea, Suwon, South Korea
  3. Kim, Jeong-ADivision of Hematology, Department of Internal Medicine, St. Vincent's hospital, The Catholic University of Korea, Suwon, South Korea
  4. Lee, Yoo JinDepartment of Hematology/Oncology, Kyungpook National University Hospital, Daegu, South Korea
  5. Chae, Yee SooDepartment of Hematology/Oncology, Kyungpook National University Hospital, Daegu, South Korea
  6. Yhim, Ho-YoungDepartment of Hematology/Oncology, Chonbuk National University Hospital, Jeonju, South Korea
  7. Kwak, Jae-YongDepartment of Hematology/Oncology, Chonbuk National University Hospital, Jeonju, South Korea
  8. Do, Young RokDepartment of Hematology/Oncology, Dongsan Medical Center, Daegu, South Korea
  9. Park, YongDepartment of Hematology/Oncology, Korea University College of Medicine, Seoul, South Korea
  10. 송무곤Department of Hematology-Oncology, Pusan National University Hospital, Pusan, South Korea
  11. 신호진Department of Hematology-Oncology, Pusan National University Hospital, Pusan, South Korea
  12. Kim, TherasaDepartment of Medical Science, Chonnam National University Hwasun Hospital, South Korea
  13. Lee, Je-jungDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, South Korea
  14. Yang, Deok-Hwan교신저자Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, South Korea

초록

This study retrospectively investigated the optimal timing of radiotherapy (RT) in patients with limited stage extranodal NK/T-cell lymphoma (ENTKL). Among 158 patients with newly diagnosed stage I/II ENKTL, 61 patients were treated with sequential chemotherapy followed by radiotherapy (SCRT), 55 with concurrent chemoradiotherapy followed by non-anthracycline-based chemotherapy (CCRT/CT), and 42 with chemotherapy (CT) only. The 5-year overall survival (OS) rate did not differ between SCRT (77.7 +/- 5.5%) and CCRT/CT (68.9 +/- 6.8%; p = 0.234). In the SCRT group, 18 patients (29.5%) relapsed within the RT field and 6 (9.8%) at systemic sites, while in the CCRT/CT group, 9 patients (16.4%) relapsed at the primary site and 14 (25.5%) at systemic sites. The 5-year cumulative incidence of relapse (CIR) at primary sites was 26.3% and 19.2% after SCRT and CCRT/CT (p = 0.308), while the 5-year CIR of systemic sites was 8.7% and 26.5% after SCRT and CCRT/CT, respectively (p = 0.010). In the multivariate analysis, NK/T-cell Prognostic Index score and CR achievement were the most important prognostic factors for survival. Although up-front RT had limitations in systemic disease control and was associated with an increased risk of systemic relapse during RT compared to SCRT, timing of RT did not significantly affect survival outcomes. (C) 2016 Published by Elsevier Ltd.

키워드

Extranodal NK/T cell lymphomaRadiotherapyChemotherapyRelapseNATURAL KILLER/T-CELLT-CELLNASAL-TYPEL-ASPARAGINASECHEMOTHERAPYTRANSPLANTATIONRADIATIONIIEIECLASSIFICATION

식별자

WoS UID
000388314100013